Colorectal cancer patient Mark Bassett won a Porsche in the Blue Hope Bash car raffle, bringing unexpected joy and new experiences amid his cancer journey.
A new report reveals how 340B program abuse fails low-income patients, increases the federal deficit, and raises employer health plan costs. Congress must act to fix 340B.
The Colorectal Cancer Alliance outlines 2025 advocacy priorities under the Trump administration and Republican-controlled Congress, including funding research and improving care access.
The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.
Allies shared their stories and the vital need to end colorectal cancer in this video presented at the national Blue Hope Bash in November 2024. The video features Bash co-chair and patient Alison Friedman.
Uncover key survey findings on the unmet psychosocial and physical needs of colorectal cancer patients and survivors, and learn how the Alliance is shaping better care.
Learn how triathlete and father Paul Weigel overcame stage III colorectal cancer, wrote "Iron Dad," and inspires early detection and candid GI discussions.
A common method for educating a new administration about an organization’s cause — and sharing how the president can improve the situation for the American people — is through a document called a transition memo.
The meetings are part of a broader government advocacy initiative by the Alliance to address the growing prevalence of CRC and improve patient care, advance research, and break down regulatory barriers that limit access to life-saving treatments.
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.